These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9170340)

  • 1. Nitric oxide synthase inhibition in the histamine headache model.
    Schmetterer L; Wolzt M; Graselli U; Findl O; Strenn K; Simak S; Kastner J; Eichler HG; Singer EA
    Cephalalgia; 1997 May; 17(3):175-82. PubMed ID: 9170340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs.
    Lassen LH; Christiansen I; Iversen HK; Jansen-Olesen I; Olesen J
    Cephalalgia; 2003 Nov; 23(9):877-86. PubMed ID: 14616929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man.
    Schmetterer L; Krejcy K; Kastner J; Wolzt M; Gouya G; Findl O; Lexer F; Breiteneder H; Fercher AF; Eichler HG
    Exp Eye Res; 1997 Mar; 64(3):305-12. PubMed ID: 9196381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans.
    Schmetterer L; Findl O; Strenn K; Graselli U; Kastner J; Eichler HG; Wolzt M
    Am J Physiol; 1997 Dec; 273(6):R2005-12. PubMed ID: 9435655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
    Dorner GT; Garhöfer G; Selenko N; Fasching P; Bayerle-Eder M; Schmetterer L; Wolzt M
    Graefes Arch Clin Exp Ophthalmol; 2003 Aug; 241(8):619-24. PubMed ID: 12836035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
    Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
    Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide.
    Kiss B; Dallinger S; Findl O; Rainer G; Eichler HG; Schmetterer L
    Am J Physiol; 1999 Jun; 276(6):R1661-7. PubMed ID: 10362745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen.
    Jilma B; Pernerstorfer T; Dirnberger E; Stohlawetz P; Schmetterer L; Singer EA; Grasseli U; Eichler HG; Kapiotis S
    J Lab Clin Med; 1998 Feb; 131(2):151-6. PubMed ID: 9488498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and ocular blood flow in patients with IDDM.
    Schmetterer L; Findl O; Fasching P; Ferber W; Strenn K; Breiteneder H; Adam H; Eichler HG; Wolzt M
    Diabetes; 1997 Apr; 46(4):653-8. PubMed ID: 9075807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man.
    Jilma B; Dirnberger E; Eichler HG; Matulla B; Schmetterer L; Kapiotis S; Speiser W; Wagner OF
    Thromb Haemost; 1997 Oct; 78(4):1268-71. PubMed ID: 9364996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of nitric oxide synthase has an analgesic effect in chronic pain].
    Ashina M; Lassen LH; Bendtsen L; Jensen RA; Olesen J
    Ugeskr Laeger; 2000 Jan; 162(2):171-3. PubMed ID: 10647315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
    Nazir FS; Alem M; Small M; Connell JM; Lees KR; Walters MR; Cleland SJ
    Diabet Med; 2006 Apr; 23(4):398-402. PubMed ID: 16620268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects.
    Luksch A; Polak K; Beier C; Polska E; Wolzt M; Dorner GT; Eichler HG; Schmetterer L
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3080-4. PubMed ID: 10967067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-induced biphasic macromolecular leakage in the microcirculation of the conscious hamster: evidence for a delayed nitric oxide-dependent leakage.
    Gimeno G; Carpentier PH; Desquand-Billiald S; Hanf R; Finet M
    Br J Pharmacol; 1998 Mar; 123(5):943-51. PubMed ID: 9535024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial.
    Ashina M; Lassen LH; Bendtsen L; Jensen R; Olesen J
    Lancet; 1999 Jan; 353(9149):287-9. PubMed ID: 9929022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
    Bellien J; Iacob M; Eltchaninoff H; Bourkaib R; Thuillez C; Joannides R
    Clin Sci (Lond); 2007 Jun; 112(7):393-401. PubMed ID: 17125466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model.
    Schmetterer L; Wolzt M; Krejcy K; Graselli U; Findl O; Eichler HG; Singer EA
    Clin Pharmacol Ther; 1996 Aug; 60(2):199-205. PubMed ID: 8823238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C; Leuschner S; Schwanebeck U; Kirch W
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans.
    White RP; Vallance P; Markus HS
    Clin Sci (Lond); 2000 Dec; 99(6):555-60. PubMed ID: 11099400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.